Among the most successful fund investment fields, there are Biotechnology, Health Care. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Biohaven Pharmaceutical.
The usual cause for the fund is to invest in rounds with more than 10 partakers. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Venrock, Rock Springs Capital.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2016. The increased amount of exits for fund were in 2017.
Related Funds
| Fund Name | Location |
| Ali Capital | California, San Francisco, United States |
| Array Ventures | California, San Francisco, United States |
| Big Sky Partners | California, Sausalito, United States |
| Capital Invest | North Carolina, Raleigh, United States |
| Charterhouse Capital Partners | England, London, United Kingdom |
| DEFT | Alabama, Birmingham, United States |
| Evli | Finland, Helsinki, Southern Finland |
| i2E Management Company | - |
| KM Medical Software | Cork, County Cork, Ireland |
| MyPreferred Transformation | - |
| Prelude | Salt Lake City, United States, Utah |
| Shenzhen Xiande Investment Holdings | China, Guangdong, Shenzhen |
| Silicon Gardens Angel Fund | - |
| Soma Capital | California, San Francisco, United States |
| Sputnik Ventures | Barcelona, Catalonia, Spain |
| Telluride Venture Fund | - |
| Tyco International | New Jersey, Princeton, United States |
| X.D. Network | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 